In Brief: Li Medical Technologies
This article was originally published in The Gray Sheet
Executive Summary
Li Medical Technologies: Privately held fixation technology firm is developing a new minimally invasive "sutureless suspension approach to bladder neck suspension surgery" for treatment of female incontinence, states Scott Gillis, president, at the March 6 UBS Securities women's health conference in New York City. The Shelton, Connecticut-based firm, which has 12 employees and was founded in 1991, also is developing products for spinal fusion. Its current product, the UltraFix suture anchor, was launched in the U.S. in December 1995 and is used for bladder neck suspension and for sports medicine applications...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.